Syndax Pharmaceuticals, Inc. (SNDX) Cash Flow Statement
Syndax Pharmaceuticals, Inc. (SNDX) generated -$220.6M of operating cash flow over the twelve months to 2026-06-30, spent $227000 on capital expenditure and had free cash flow of -$220.9M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SNDXSyndax Pharmaceuticals, Inc.Follow SNDX — free
—
Price chart with a free account
- Market cap
- 1.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -35.2 | -47.4 | -68.5 | -50.6 | -71.3 | 29.1 | -274.9 | -323.0 | -220.6 | |
| Capital expenditure | 0.3 | 0.1 | 0.2 | — | 0.0 | 0.1 | 0.0 | 0.2 | -0.2 | |
| Free cash flow | -35.4 | -47.5 | -68.7 | — | -71.3 | 29.0 | -274.9 | -323.2 | -220.9 | |
| Stock-based compensation | 4.7 | 5.5 | 6.2 | 6.0 | 9.1 | 13.3 | 43.0 | 47.5 | — |
USD millions · SEC XBRL
Syndax Pharmaceuticals, Inc. — questions
- What is Syndax Pharmaceuticals, Inc.'s operating cash flow?
- -$220.6M over the twelve months to 2026-06-30.
- How much does Syndax Pharmaceuticals, Inc. spend on capital expenditure?
- $227000 over the twelve months to 2026-06-30.
- What is Syndax Pharmaceuticals, Inc.'s free cash flow?
- -$220.9M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Syndax Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.